1. American Cancer Society. Cancer facts & figures 2012. www.cancer.org/acs/groups/content/@epidemiologysurveillance/documents/document/acspc-031941.pdf (accessed 2013 Jan 4).
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer. www.nccn.org/professionals/physician_gls/pdf/prostate.pdf [registration required] (accessed 2013 Jan 7).
3. Food and Drug Administration. FDA approves new indication for Taxotere—prostate cancer. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108301.htm (accessed 2011 Aug 1).
4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
5. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010